CBT vs OLN
As of Sep 20, 2026, Cabot (CBT) scores 6.2/10 and OLIN Corp (OLN) 2.3/10 on AlphaStocks' five-model composite, so CBT scores higher.
CBT
CABOT CORP
6.2
Consider Buy
$77.36
OLN
OLIN Corp
2.3
Avoid
$16.83
CBT vs OLN: Which is the Better Investment?
CABOT CORP (CBT) scores 6.2/10 while OLIN Corp (OLN) scores 2.3/10 on AlphaStocks' composite model. CABOT CORP has the higher composite rating of Consider Buy.
This comparison is algorithmically generated and is not financial advice.
| Metric | CBT | OLN |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 6.2/10▲ | 2.3/10 |
| Rating | Consider Buy▲ | Avoid |
| Price | $77.36 | $16.83 |
| P/E Ratio | 12.7 | — |
| ROE | 21.4%▲ | -4.9% |
| Market Cap | $4B | $2B |
| Fair Value | — | — |
| Dividend Yield | 2.0% | 3.9%▲ |
| Sector Rank | #11 of 78▲ | #69 of 78 |
| Model Verdicts | ||
| Piotroski | Attractive▲ | Neutral |
| Buffett | Strong▲ | Neutral |
| Graham | Neutral | Neutral |
| Lynch | Neutral | Neutral |
| Greenblatt | Strong▲ | Caution |
Related comparisons
CBT vs OLN: Which Stock Scores Higher?
CABOT CORP (CBT) and OLIN Corp (OLN) are both in the Materials sector. CBT currently leads with a composite score of 6.2/10 (Consider Buy) compared to OLN's 2.3/10 (Avoid).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer